Centogene and denali therapeutics extend world's largest observational study on parkinson's disease genetics

Working together to deliver data-driven, informative genotyping answers to accelerate and de-risk drug discovery, development, and commercialization for parkinson's disease (pd) working together to deliver data-driven, informative genotyping answers to accelerate and de-risk drug discovery, development, and commercialization for parkinson's disease (pd)
CNTG Ratings Summary
CNTG Quant Ranking